GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioRegenx BRGX · USD

Communication Services · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.9m

FY2015FY2025

Net income

−$1.5m

FY2015FY2025

Free cash flow

$29,915

FY2015FY2025

Shareholders' equity

−$4.5m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Revenue$1.9m$2.3m$22,243$42,159$198,584$404,392$478,060$257,913$268,545$343,682
Research and development————$1.2m$317,598————
Operating income−$518,991−$22.8m−$110,000−$78,308−$165,000−$216,000−$210,000−$47,326−$74,100$11,990
Net income−$1.5m−$23.1m−$571,000−$78,308−$96,873−$332,000−$208,000−$47,326−$81,375$9,417
Diluted earnings per share-0.00-0.02-0.00-0.00-0.00-0.00-0.00-0.00-0.000.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Total assets$410,986$508,535$31,640$59,149$127,762$367,700$91,760$61,628—$101,847
Cash and short-term investments$69,383$58,404$125,402$676$24,358$93,875$37,975$3,129—$6,576
Total liabilities$4.9m$3.9m$253,612$260,691$211,996$190,061$77,517$75,592—$73,022
Debt$2.2m$2.2m$225,370$240,970$200,000$150,000−$6,500———
Shareholders' equity−$4.5m−$3.4m−$221,972−$201,542−$84,234$177,639$14,243$45,470—$28,825
Shares outstanding969m957m277m270m270m275m969m969m969m969m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Cash from operations$38,972−$324,148−$13,347−$64,652−$119,517−$94,100−$142,275−$56,678——
Capital spending−$9,057−$189,390−$49,363—−$31,547—————
Free cash flow$29,915−$513,538−$62,710−$64,652−$151,064−$94,100−$142,275−$56,678——

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue$426,175$385,641$507,755$445,970$515,147$460,489$596,037$734,032
Operating income−$49,764−$210,658−$8,459−$107,259−$192,615−$2.1m−$327,307−$1.0m
Net income−$26,415−$1.0m−$80,565−$178,345−$267,000−$18.4m−$395,000−$1.1m
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.02-0.00-0.00
Capital spending————−$18.0m—−$18.0m—
Total assets$337,070$410,986$1.2m$1.2m$482,623$508,535$17.4m$17.9m
Cash and short-term investments$45,806—$46,947$46,456$83,625—$70,081—
Debt$2.2m$181,825$2.3m$2.2m$2.2m$254,606$2.2m$249,599
Shareholders' equity−$4.5m−$4.5m−$3.6m−$3.7m−$3.6m−$3.4m$13.6m$14.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue253.0%35.6%25.5%
Operating income87.8%19.2%31.0%
Net income170.1%36.0%45.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-555.1%-551.1%-490.6%-378.1%
Net margin-586.4%-592.8%-528.1%-406.8%

Valuation history

At each fiscal year end

FY2025FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-8.1—-0.0-0.0-0.0-0.0-0.0
Price to sales6.70.10.10.00.0——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return183355%100%31%-49%-76%1086%148%47399%320%1574%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 30-to-1 reverse split · 25 Mar 2011
  • 100-to-1 reverse split · 8 Jul 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.